Valuation Takeda Pharmaceutical Company Limited NYSE

Stocks

TAK

US8740602052

Pharmaceuticals

Market Closed - NYSE Other stock markets 16:00:03 2026-07-31 EDT			5-day change	1st Jan Change
17.09 ^USD	-0.93%		-0.87%	+9.62%

07-30	Keros Therapeutics to Receive $20 Million Development Milestone Payment From Takeda	DJ
07-30	Takeda Pharmaceutical Company Limited, Q1 2027 Earnings Call, Jul 30, 2026

Company Valuation: Takeda Pharmaceutical Company Limited

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	5,423,454	6,762,204	6,564,378	6,749,675	8,948,061	8,802,931	-	-
Change	-	24.68%	-2.93%	2.82%	32.57%	-1.62%	-	-
Enterprise Value (EV) ¹	8,919,170	10,611,015	10,950,330	10,725,175	5,130,461	12,736,530	12,586,968	12,271,981
Change	-	18.97%	3.2%	-2.06%	-52.16%	148.25%	-1.17%	-2.5%
P/E	23.8x	21.3x	45.4x	64.6x	46.4x	44.3x	27.4x	22.1x
PBR	0.95x	1.06x	0.9x	1x	1.2x	1.18x	1.17x	1.16x
PEG	-	0.5x	-0.8x	-2.5x	0.6x	21.13x	0.4x	0.9x
Capitalization / Revenue	1.52x	1.68x	1.54x	1.47x	1.99x	1.89x	1.86x	1.81x
EV / Revenue	2.5x	2.63x	2.57x	2.34x	1.14x	2.73x	2.66x	2.52x
EV / EBITDA	8.54x	9.19x	11.6x	9.71x	4.54x	9.18x	8.91x	8.27x
EV / EBIT	19.4x	21.6x	51.1x	31.3x	12.6x	27.9x	21.1x	17.5x
EV / FCF	8.92x	28.7x	43.4x	15.5x	8.14x	16.7x	16.6x	15.2x
FCF Yield	11.2%	3.49%	2.31%	6.43%	12.3%	5.99%	6.02%	6.57%
Dividend per Share ²	180	180	188	196	200	204.4	209.2	216.1
Rate of return	5.15%	4.14%	4.49%	4.44%	3.53%	3.71%	3.8%	3.92%
EPS ²	147.1	204.3	92.09	68.36	122	124.6	200.9	249.9
Distribution rate	122%	88.1%	204%	287%	164%	164%	104%	86.5%
Net sales ¹	3,569,006	4,027,478	4,263,762	4,581,600	4,505,700	4,662,349	4,739,549	4,862,429
EBITDA ¹	1,043,995	1,154,905	942,077	1,103,982	1,129,888	1,388,131	1,412,239	1,483,795
EBIT ¹	460,844	490,505	214,100	342,600	408,800	456,820	595,162	702,983
Net income ¹	230,059	317,017	144,067	107,900	191,800	185,815	313,331	379,936
Net Debt ¹	3,495,716	3,848,811	4,385,952	3,975,500	-3,817,600	3,933,599	3,784,037	3,469,050
Reference price ²	3,498.00	4,350.00	4,184.00	4,413.00	5,664.00	5,513.00	5,513.00	5,513.00
Nbr of stocks (in thousands)	1,550,444	1,554,530	1,568,924	1,529,498	1,579,813	1,596,759	-	-
Announcement Date	5/11/22	5/11/23	5/9/24	5/8/25	5/13/26	-	-	-

¹JPY in Million²JPY

Estimates

P/E, Detailed evolution

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	34.3x	12.25x	25.74x	0.59%	1,030B
JOHNSON & JOHNSON	27.42x	6.27x	17.37x	2.1%	617B
ABBVIE INC.	32.4x	7.6x	15.6x	2.67%	455B
ROCHE HOLDING AG	19.58x	4.68x	11.59x	2.83%	350B
NOVARTIS AG	22.31x	5.76x	14.38x	2.78%	299B
ASTRAZENECA PLC	21.88x	4.51x	12.77x	1.94%	265B
NOVO NORDISK A/S	14.62x	5.41x	11.16x	3.43%	225B
AMGEN INC.	25.46x	6.65x	11.72x	2.6%	209B
GILEAD SCIENCES, INC.	-47.31x	5.67x	31.32x	2.51%	163B
Average	16.74x	6.53x	16.85x	2.38%	401.41B
Weighted average by Cap.	24.14x	7.76x	18.30x	1.99%